Companies in the biopharmaceutical are challenging to get your arms around. The development of pharmaceutical treatments is highly technical and requires scientific insight. Further, developing these therapies is expensive and takes over a decade... if the product is successful. Most compounds fail for safety and efficacy reasons and never reach the market.
